Bionomics Historical Balance Sheet

BNOX Stock

USD 0.30 0.01 3.45%

Trend analysis of Bionomics Ltd ADR balance sheet accounts such as Short Long Term Debt Total of 259.1 K, Total Current Liabilities of 4.9 M or Total Stockholder Equity of 22.4 M provides information on Bionomics' total assets, liabilities, and equity, which is the actual value of Bionomics ADR to its prevalent stockholders. By breaking down trends over time using Bionomics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Bionomics ADR latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Bionomics ADR is a good buy for the upcoming year.

Bionomics Inventory

(435.39 Million)

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bionomics Ltd ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

About Bionomics Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Bionomics ADR at a specified time, usually calculated after every quarter, six months, or one year. Bionomics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Bionomics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Bionomics currently owns. An asset can also be divided into two categories, current and non-current.

Bionomics Balance Sheet Chart

At this time, Bionomics' Common Stock is fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 16.8 M in 2024, whereas Short and Long Term Debt Total is likely to drop slightly above 259.1 K in 2024.

Total Assets Short Long Term Debt Total Total Current Liabilities Accounts Payable

Add Fundamental

Total Assets

Total assets refers to the total amount of Bionomics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Bionomics ADR books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Bionomics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Bionomics Ltd ADR are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Accounts Payable

An accounting item on the balance sheet that represents Bionomics obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Bionomics ADR are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Most accounts from Bionomics' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Bionomics ADR current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bionomics Ltd ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

	2021	2022	2023	2024 (projected)
Short and Long Term Debt Total	477.0K	355.2K	272.7K	259.1K
Total Assets	45.1M	28.6M	19.0M	35.5M

Short Long Term Debt Total Total Assets

Bionomics balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Cash	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Other Current Liab	Property Plant And Equipment Net	Non Current Assets Total	Net Receivables	Inventory	Intangible Assets	Current Deferred Revenue	Good Will	Short Term Investments	Non Currrent Assets Other
Total Assets		0.54	0.76	0.77	-0.45	0.05	0.6	0.79	0.81	-0.21	0.75	0.81	0.73	0.97	0.41	0.2	0.6	0.68	0.89	0.38	0.3	0.87	0.3	0.69	0.37	-0.25
Short Long Term Debt Total	0.54		0.82	-0.1	0.26	0.18	0.24	0.45	0.47	-0.42	0.69	0.76	0.93	0.45	0.88	-0.23	0.87	0.89	0.57	-0.2	0.33	0.45	-0.33	0.55	0.54	-0.58
Total Current Liabilities	0.76	0.82		0.23	0.14	0.16	0.59	0.44	0.46	-0.39	0.84	0.91	0.93	0.66	0.81	-0.09	0.73	0.88	0.81	0.19	0.26	0.76	0.03	0.6	0.55	-0.2
Total Stockholder Equity	0.77	-0.1	0.23		-0.78	-0.02	0.42	0.65	0.67	0.0	0.31	0.37	0.12	0.8	-0.16	0.36	0.09	0.15	0.58	0.51	0.23	0.65	0.57	0.41	0.07	0.01
Net Debt	-0.45	0.26	0.14	-0.78		0.18	-0.25	-0.74	-0.72	-0.26	-0.02	-0.01	0.12	-0.58	0.38	-0.44	0.06	0.06	-0.2	-0.04	0.06	-0.22	-0.41	-0.08	0.24	-0.07
Retained Earnings	0.05	0.18	0.16	-0.02	0.18		0.0	-0.06	0.0	-0.92	0.02	0.37	0.07	0.08	0.16	-0.94	0.22	0.29	-0.18	0.16	0.71	0.09	0.23	-0.35	0.71	-0.03
Accounts Payable	0.6	0.24	0.59	0.42	-0.25	0.0		0.4	0.39	-0.11	0.72	0.58	0.48	0.57	0.14	0.14	0.22	0.5	0.65	0.22	-0.04	0.71	0.13	0.17	0.21	0.39
Cash	0.79	0.45	0.44	0.65	-0.74	-0.06	0.4		0.99	-0.04	0.49	0.53	0.53	0.85	0.25	0.25	0.54	0.56	0.58	-0.11	0.16	0.51	0.15	0.46	0.15	-0.33
Cash And Short Term Investments	0.81	0.47	0.46	0.67	-0.72	0.0	0.39	0.99		-0.09	0.5	0.55	0.54	0.86	0.28	0.2	0.56	0.58	0.59	-0.09	0.23	0.54	0.15	0.48	0.2	-0.36
Common Stock Shares Outstanding	-0.21	-0.42	-0.39	0.0	-0.26	-0.92	-0.11	-0.04	-0.09		-0.2	-0.58	-0.3	-0.19	-0.42	0.86	-0.44	-0.5	-0.07	-0.12	-0.77	-0.28	-0.07	0.11	-0.91	0.19
Non Current Liabilities Total	0.75	0.69	0.84	0.31	-0.02	0.02	0.72	0.49	0.5	-0.2		0.72	0.84	0.66	0.53	0.07	0.51	0.85	0.84	0.18	0.12	0.76	0.07	0.61	0.34	-0.05
Other Current Assets	0.81	0.76	0.91	0.37	-0.01	0.37	0.58	0.53	0.55	-0.58	0.72		0.86	0.75	0.67	-0.24	0.76	0.81	0.76	0.26	0.46	0.81	0.14	0.46	0.7	-0.29
Total Liab	0.73	0.93	0.93	0.12	0.12	0.07	0.48	0.53	0.54	-0.3	0.84	0.86		0.65	0.8	-0.05	0.83	0.88	0.76	0.04	0.18	0.66	-0.13	0.63	0.48	-0.39
Total Current Assets	0.97	0.45	0.66	0.8	-0.58	0.08	0.57	0.85	0.86	-0.19	0.66	0.75	0.65		0.29	0.17	0.56	0.6	0.77	0.39	0.24	0.76	0.4	0.57	0.32	-0.2
Short Term Debt	0.41	0.88	0.81	-0.16	0.38	0.16	0.14	0.25	0.28	-0.42	0.53	0.67	0.8	0.29		-0.23	0.78	0.79	0.51	-0.17	0.32	0.41	-0.28	0.5	0.53	-0.48
Common Stock	0.2	-0.23	-0.09	0.36	-0.44	-0.94	0.14	0.25	0.2	0.86	0.07	-0.24	-0.05	0.17	-0.23		-0.21	-0.25	0.35	0.03	-0.58	0.13	-0.01	0.45	-0.65	0.06
Other Current Liab	0.6	0.87	0.73	0.09	0.06	0.22	0.22	0.54	0.56	-0.44	0.51	0.76	0.83	0.56	0.78	-0.21		0.72	0.54	-0.05	0.4	0.48	-0.31	0.53	0.55	-0.63
Property Plant And Equipment Net	0.68	0.89	0.88	0.15	0.06	0.29	0.5	0.56	0.58	-0.5	0.85	0.81	0.88	0.6	0.79	-0.25	0.72		0.67	-0.08	0.42	0.62	-0.05	0.52	0.59	-0.33
Non Current Assets Total	0.89	0.57	0.81	0.58	-0.2	-0.18	0.65	0.58	0.59	-0.07	0.84	0.76	0.76	0.77	0.51	0.35	0.54	0.67		0.3	0.15	0.93	0.1	0.78	0.31	-0.2
Net Receivables	0.38	-0.2	0.19	0.51	-0.04	0.16	0.22	-0.11	-0.09	-0.12	0.18	0.26	0.04	0.39	-0.17	0.03	-0.05	-0.08	0.3		0.15	0.37	0.61	0.25	0.11	0.19
Inventory	0.3	0.33	0.26	0.23	0.06	0.71	-0.04	0.16	0.23	-0.77	0.12	0.46	0.18	0.24	0.32	-0.58	0.4	0.42	0.15	0.15		0.3	0.08	0.22	0.6	-0.52
Intangible Assets	0.87	0.45	0.76	0.65	-0.22	0.09	0.71	0.51	0.54	-0.28	0.76	0.81	0.66	0.76	0.41	0.13	0.48	0.62	0.93	0.37	0.3		0.21	0.56	0.45	-0.08
Current Deferred Revenue	0.3	-0.33	0.03	0.57	-0.41	0.23	0.13	0.15	0.15	-0.07	0.07	0.14	-0.13	0.4	-0.28	-0.01	-0.31	-0.05	0.1	0.61	0.08	0.21		-0.05	0.0	0.35
Good Will	0.69	0.55	0.6	0.41	-0.08	-0.35	0.17	0.46	0.48	0.11	0.61	0.46	0.63	0.57	0.5	0.45	0.53	0.52	0.78	0.25	0.22	0.56	-0.05		0.09	-0.56
Short Term Investments	0.37	0.54	0.55	0.07	0.24	0.71	0.21	0.15	0.2	-0.91	0.34	0.7	0.48	0.32	0.53	-0.65	0.55	0.59	0.31	0.11	0.6	0.45	0.0	0.09		-0.22
Non Currrent Assets Other	-0.25	-0.58	-0.2	0.01	-0.07	-0.03	0.39	-0.33	-0.36	0.19	-0.05	-0.29	-0.39	-0.2	-0.48	0.06	-0.63	-0.33	-0.2	0.19	-0.52	-0.08	0.35	-0.56	-0.22

Click cells to compare fundamentals

Bionomics Account Relationship Matchups

Bionomics balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	23.8M	40.7M	45.1M	28.6M	19.0M	35.5M
Short Long Term Debt Total	8.4M	651.5K	477.0K	355.2K	272.7K	259.1K
Total Current Liabilities	5.7M	1.8M	2.3M	2.8M	2.6M	4.9M
Total Stockholder Equity	8.8M	35.7M	39.3M	22.1M	11.7M	22.4M
Net Debt	5.3M	(20.7M)	(22.7M)	(11.8M)	(12.4M)	(13.0M)
Retained Earnings	(102.8M)	(115.5M)	(119.7M)	(136.4M)	(178.0M)	(169.1M)
Accounts Payable	870.6K	772.9K	1.1M	1.4M	2.2M	1.6M
Cash	3.2M	21.4M	23.2M	12.2M	12.6M	14.2M
Cash And Short Term Investments	3.2M	21.4M	23.2M	12.2M	8.4M	14.0M
Common Stock Shares Outstanding	3.0M	4.3M	7.5M	8.2M	10.0M	10.5M
Liabilities And Stockholders Equity	23.7M	40.7M	44.9M	28.6M	27.6M	35.9M
Non Current Liabilities Total	4.3M	3.2M	3.5M	3.8M	4.7M	5.9M
Other Current Assets	2.6M	974.1K	1.0M	797.5K	306.4K	291.1K
Total Liab	15.0M	5.0M	5.8M	6.6M	10.2M	13.3M
Total Current Assets	5.8M	23.2M	28.9M	13.4M	13.2M	19.7M
Short Term Debt	4.1M	130.9K	110.1K	113.9K	155.1K	147.4K
Common Stock	102.2M	142.6M	150.3M	148.8M	171.1M	179.7M
Other Current Liab	4.8M	866.2K	1.1M	1.2M	158.5K	150.6K
Property Plant And Equipment Net	728.1K	653.1K	465.7K	334.5K	146.2K	138.9K
Non Current Assets Total	17.7M	17.4M	16.1M	15.2M	14.5M	16.8M
Net Receivables	12.1K	849.9K	4.7M	426.1K	84.7K	80.5K
Inventory	1.13	1.0	(4.7M)	(427.8K)	(458.3M)	(435.4M)
Intangible Assets	8.1M	7.5M	6.8M	6.1M	3.7M	7.0M
Current Deferred Revenue	(4.1M)	(130.8K)	(110.1K)	(114.4K)	(796.8K)	(756.9K)
Good Will	8.9M	9.3M	8.9M	8.7M	5.8M	7.5M
Accumulated Other Comprehensive Income	9.2M	8.6M	8.6M	9.7M	(2.0M)	(1.9M)
Non Currrent Assets Other	(17.7M)	(17.4M)	(16.1M)	(15.2M)	4.8M	5.0M
Other Assets	301.0K	89.2K	82.2K	79.3K	(8.7M)	(8.3M)
Other Stockholder Equity	21.9K	(32.5K)	(31.4K)	1.0	191.7M	201.3M
Other Liab	7.2M	3.6M	4.5M	5.4M	4.8M	7.1M
Net Tangible Assets	(12.0M)	25.3M	34.2M	10.9M	12.5M	7.4M
Net Invested Capital	24.1M	47.6M	56.9M	33.1M	17.5M	28.9M
Non Current Liabilities Other	5.0M	1.8M	2.7M	3.7M	590.6K	561.1K
Net Working Capital	60.8K	28.6M	38.5M	16.0M	9.4M	8.9M
Property Plant Equipment	1.1M	870.9K	674.5K	502.3K	452.0K	429.4K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

Additional Tools for Bionomics Stock Analysis

When running Bionomics' price analysis, check to measure Bionomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bionomics is operating at the current time. Most of Bionomics' value examination focuses on studying past and present price action to predict the probability of Bionomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bionomics' price. Additionally, you may evaluate how the addition of Bionomics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Bionomics Historical Balance Sheet

Bionomics Inventory

(435.39 Million)

About Bionomics Balance Sheet Analysis

Bionomics Balance Sheet Chart

Total Assets

Total Current Liabilities

Accounts Payable

Bionomics balance sheet Correlations

Bionomics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Bionomics balance sheet Accounts

Also Currently Popular

Additional Tools for Bionomics Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 0.99	Cash
Total Current Assets	+ 0.97	Total Assets
Total Liab	+ 0.93	Short Long Term Debt Total
Total Liab	+ 0.93	Total Current Liabilities
Intangible Assets	+ 0.93	Non Current Assets Total
Other Current Assets	+ 0.91	Total Current Liabilities

Common Stock	- 0.94	Retained Earnings
Common Stock Shares Outstanding	- 0.92	Retained Earnings
Short Term Investments	- 0.91	Common Stock Shares Outstanding
Net Debt	- 0.78	Total Stockholder Equity
Inventory	- 0.77	Common Stock Shares Outstanding
Cash	- 0.74	Net Debt